Richard Gonzalez, AP Images
AbbVie puts an end to Botox trade secrets suit, imposes royalty, license deal on competitor Evolus
The crown jewel of AbbVie’s big-dollar acquisition of Allergan, Botox is one of the most recognizable brands in pharma — and both drugmakers have worked …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
